Limits...
Predictability of the individual clinical outcome of extracorporeal shock wave therapy for cellulite.

Schlaudraff KU, Kiessling MC, Császár NB, Schmitz C - Clin Cosmet Investig Dermatol (2014)

Bottom Line: Compared with baseline, no patient's condition worsened, the treatment was well tolerated, and no unwanted side effects were observed.No statistically significant (ie, P<0.05) correlation was found between individual values for δ-1 and δ-2 and cellulite grade at baseline, BMI, weight, height, or age.The individual clinical outcome cannot be predicted by the patient's individual cellulite grade at baseline, BMI, weight, height, or age.

View Article: PubMed Central - PubMed

Affiliation: Concept Clinic, Geneva, Switzerland.

ABSTRACT

Background: Extracorporeal shock wave therapy has been successfully introduced for the treatment of cellulite in recent years. However, it is still unknown whether the individual clinical outcome of cellulite treatment with extracorporeal shock wave therapy can be predicted by the patient's individual cellulite grade at baseline, individual patient age, body mass index (BMI), weight, and/or height.

Methods: Fourteen Caucasian females with cellulite were enrolled in a prospective, single-center, randomized, open-label Phase II study. The mean (± standard error of the mean) cellulite grade at baseline was 2.5±0.09 and mean BMI was 22.8±1.17. All patients were treated with radial extracorporeal shock waves using the Swiss DolorClast(®) device (Electro Medical Systems, S.A., Nyon, Switzerland). Patients were treated unilaterally with 2 weekly treatments for 4 weeks on a randomly selected side (left or right), totaling eight treatments on the selected side. Treatment was performed at 3.5-4.0 bar, with 15,000 impulses per session applied at 15 Hz. Impulses were homogeneously distributed over the posterior thigh and buttock area (resulting in 7,500 impulses per area). Treatment success was evaluated after the last treatment and 4 weeks later by clinical examination, photographic documentation, contact thermography, and patient satisfaction questionnaires.

Results: The mean cellulite grade improved from 2.5±0.09 at baseline to 1.57±0.18 after the last treatment (ie, mean δ-1 was 0.93 cellulite grades) and 1.68±0.16 at follow-up (ie, mean δ-2 was 0.82 cellulite grades). Compared with baseline, no patient's condition worsened, the treatment was well tolerated, and no unwanted side effects were observed. No statistically significant (ie, P<0.05) correlation was found between individual values for δ-1 and δ-2 and cellulite grade at baseline, BMI, weight, height, or age.

Conclusion: Radial shock wave therapy is a safe and effective treatment option for cellulite. The individual clinical outcome cannot be predicted by the patient's individual cellulite grade at baseline, BMI, weight, height, or age.

No MeSH data available.


Related in: MedlinePlus

Radial shock wave therapy for cellulite.Notes: (A) Application of coupling gel. (B) Treatment with the Power+ hand piece of the Swiss DolorClast® device (Electro Medical Systems, Nyon, Switzerland).
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4043818&req=5

f2-ccid-7-171: Radial shock wave therapy for cellulite.Notes: (A) Application of coupling gel. (B) Treatment with the Power+ hand piece of the Swiss DolorClast® device (Electro Medical Systems, Nyon, Switzerland).

Mentions: All patients were treated with radial extracorporeal shock waves using the Swiss DolorClast device (Electro Medical Systems, SA, Nyon, Switzerland) and the Swiss DolorClast Power+ hand piece with the 36 mm applicator (Figure 1). Patients were positioned on a treatment table as indicated in Figure 2 and the areas of the posterior thigh and the anatomical buttock area were treated. The medial and lateral lines of the thigh served as borders of the treatment area which extended superiorly until the buttock crease and inferiorly 5 cm above the popliteal crease.


Predictability of the individual clinical outcome of extracorporeal shock wave therapy for cellulite.

Schlaudraff KU, Kiessling MC, Császár NB, Schmitz C - Clin Cosmet Investig Dermatol (2014)

Radial shock wave therapy for cellulite.Notes: (A) Application of coupling gel. (B) Treatment with the Power+ hand piece of the Swiss DolorClast® device (Electro Medical Systems, Nyon, Switzerland).
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4043818&req=5

f2-ccid-7-171: Radial shock wave therapy for cellulite.Notes: (A) Application of coupling gel. (B) Treatment with the Power+ hand piece of the Swiss DolorClast® device (Electro Medical Systems, Nyon, Switzerland).
Mentions: All patients were treated with radial extracorporeal shock waves using the Swiss DolorClast device (Electro Medical Systems, SA, Nyon, Switzerland) and the Swiss DolorClast Power+ hand piece with the 36 mm applicator (Figure 1). Patients were positioned on a treatment table as indicated in Figure 2 and the areas of the posterior thigh and the anatomical buttock area were treated. The medial and lateral lines of the thigh served as borders of the treatment area which extended superiorly until the buttock crease and inferiorly 5 cm above the popliteal crease.

Bottom Line: Compared with baseline, no patient's condition worsened, the treatment was well tolerated, and no unwanted side effects were observed.No statistically significant (ie, P<0.05) correlation was found between individual values for δ-1 and δ-2 and cellulite grade at baseline, BMI, weight, height, or age.The individual clinical outcome cannot be predicted by the patient's individual cellulite grade at baseline, BMI, weight, height, or age.

View Article: PubMed Central - PubMed

Affiliation: Concept Clinic, Geneva, Switzerland.

ABSTRACT

Background: Extracorporeal shock wave therapy has been successfully introduced for the treatment of cellulite in recent years. However, it is still unknown whether the individual clinical outcome of cellulite treatment with extracorporeal shock wave therapy can be predicted by the patient's individual cellulite grade at baseline, individual patient age, body mass index (BMI), weight, and/or height.

Methods: Fourteen Caucasian females with cellulite were enrolled in a prospective, single-center, randomized, open-label Phase II study. The mean (± standard error of the mean) cellulite grade at baseline was 2.5±0.09 and mean BMI was 22.8±1.17. All patients were treated with radial extracorporeal shock waves using the Swiss DolorClast(®) device (Electro Medical Systems, S.A., Nyon, Switzerland). Patients were treated unilaterally with 2 weekly treatments for 4 weeks on a randomly selected side (left or right), totaling eight treatments on the selected side. Treatment was performed at 3.5-4.0 bar, with 15,000 impulses per session applied at 15 Hz. Impulses were homogeneously distributed over the posterior thigh and buttock area (resulting in 7,500 impulses per area). Treatment success was evaluated after the last treatment and 4 weeks later by clinical examination, photographic documentation, contact thermography, and patient satisfaction questionnaires.

Results: The mean cellulite grade improved from 2.5±0.09 at baseline to 1.57±0.18 after the last treatment (ie, mean δ-1 was 0.93 cellulite grades) and 1.68±0.16 at follow-up (ie, mean δ-2 was 0.82 cellulite grades). Compared with baseline, no patient's condition worsened, the treatment was well tolerated, and no unwanted side effects were observed. No statistically significant (ie, P<0.05) correlation was found between individual values for δ-1 and δ-2 and cellulite grade at baseline, BMI, weight, height, or age.

Conclusion: Radial shock wave therapy is a safe and effective treatment option for cellulite. The individual clinical outcome cannot be predicted by the patient's individual cellulite grade at baseline, BMI, weight, height, or age.

No MeSH data available.


Related in: MedlinePlus